Add to ORKGPrimary aldosteronism remains a leading cause of secondary hypertension, and its diagnosis and management continue to pose a challenge for clinicians. In this article, we review the diagnosis of primary aldosteronism along with its cardiovascular manifestations. Treatment is described depending on the diagnostic outcome, focusing on medical management with mineralocorticoid receptor antagonists and unilateral adrenalectomy. Although screening and diagnosing hyperaldosteronism follows well-known algorithms, in practice, physicians may find difficulty establishing the best course of action due to complexity in testing and confirming laterality of aldosterone production by the adrenals. Recognizing and treating primary aldosteronism requires a...
Objective: To develop clinical practice guidelines for the management of patients with primary aldos...
Primary aldosteronism affects 5–13 % of patients with hyper-tension. Patients with hypertension and ...
Primary aldosteronism (PA) is a common, but frequently overlooked, cause of arterial hypertension an...
Primary aldosteronism remains a leading cause of secondary hypertension, and its diagnosis and manag...
Primary aldosteronism (PA) is the most common secondary form of arterial hypertension, with a partic...
Primary aldosteronism (PA) is the most common secondary form of arterial hypertension, with a partic...
ABSTRACT Primary aldosteronism (PA) is the most common form of secondary hypertension (HTN), with an...
Primary aldosteronism (PA) is an important and commonly unrecognized cause of secondary hypertension...
BACKGROUND: Primary aldosteronism is much more common than previously held; it implies an excessive ...
Primary aldosteronism is the most common form of endocrine hypertension and is highly prevalent amon...
Primary aldosteronism (PA) is common with an estimated prevalence rate of 10% in subjects with essen...
Recent studies have indicated a higher prevalence of primary aldosteronism (PA) than reported histor...
Compelling evidences showed that primary aldosteronism (PA) is a quite common disease. In spite of t...
Primary aldosteronism is the most common form of endocrine hypertension and is highly prevalent amon...
Primary aldosteronism (PA) is a highly prevalent cause of arterial hypertension featuring excess car...
Objective: To develop clinical practice guidelines for the management of patients with primary aldos...
Primary aldosteronism affects 5–13 % of patients with hyper-tension. Patients with hypertension and ...
Primary aldosteronism (PA) is a common, but frequently overlooked, cause of arterial hypertension an...
Primary aldosteronism remains a leading cause of secondary hypertension, and its diagnosis and manag...
Primary aldosteronism (PA) is the most common secondary form of arterial hypertension, with a partic...
Primary aldosteronism (PA) is the most common secondary form of arterial hypertension, with a partic...
ABSTRACT Primary aldosteronism (PA) is the most common form of secondary hypertension (HTN), with an...
Primary aldosteronism (PA) is an important and commonly unrecognized cause of secondary hypertension...
BACKGROUND: Primary aldosteronism is much more common than previously held; it implies an excessive ...
Primary aldosteronism is the most common form of endocrine hypertension and is highly prevalent amon...
Primary aldosteronism (PA) is common with an estimated prevalence rate of 10% in subjects with essen...
Recent studies have indicated a higher prevalence of primary aldosteronism (PA) than reported histor...
Compelling evidences showed that primary aldosteronism (PA) is a quite common disease. In spite of t...
Primary aldosteronism is the most common form of endocrine hypertension and is highly prevalent amon...
Primary aldosteronism (PA) is a highly prevalent cause of arterial hypertension featuring excess car...
Objective: To develop clinical practice guidelines for the management of patients with primary aldos...
Primary aldosteronism affects 5–13 % of patients with hyper-tension. Patients with hypertension and ...
Primary aldosteronism (PA) is a common, but frequently overlooked, cause of arterial hypertension an...